The use of fibrin sealant (Tisseel) in laparoscopic excision of ovarian endometrioma

Yu-Cheng Liu, Yucheng Liu, Yi-Chieh Li, Hsin-Hong Kuo, Chin-Jung Wang, Chin‐Jung Wang, Kai‐Yun Wu, Kai-Yun Wu
Taiwanese journal of obstetrics & gynecology · 2017 · vol. 56(3) , pp. 342–345 · doi:10.1016/j.tjog.2017.04.014 · PMID:28600045 · W2624160155
article OA: diamond CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study evaluated Tisseel fibrin sealant for hemostasis and ovarian defect repair during laparoscopic endometrioma excision, finding it safe and feasible without affecting operative time or hospital stay.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the use of Tisseel, a 2-component fibrin sealant agent for the control of minor bleeding and repair of the ovarian defect at the end of laparoscopic cystectomy (LC) of endometriomas. MATERIALS AND METHODS: From January 2011 to December 2015, an observational study of all patients who underwent LC of endometrioma using Tisseel (group A) was performed. The demographic and operative data, including age, body mass index, operative indications, operative time, estimated blood loss, complications, and postoperative hospital stay duration were recorded. A contemporary cohort of patients, who underwent LC of endometrioma without Tisseel (group B) was also retrospectively compared. RESULTS: A total of 274 patients were recruited in this study (53 LCs with Tisseel and 221 LCs without Tisseel, respectively). Complete hemostasis was achieved in all patients. The mean size of main mass was significantly larger in the group A than in the group B (7.8 ± 2.4 cm vs. 7.0 ± 2.3 cm, p = 0.033) but the mean operating time, operative blood loss, febrile morbidity, and length of hospitalization were not significantly different between the two groups. CONCLUSION: This preliminary series demonstrated the use of Tisseel in LC of endometriomas without any bipolar coagulation and/or suturing of ovarian tissue is clinically safe and feasible.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometrioma

MeSH descriptors

Endometriosis Fibrin Tissue Adhesive Hemostasis, Surgical Ovarian Diseases Tissue Adhesives Adult Blood Loss, Surgical Case-Control Studies Endometriosis Endometriosis Female Fibrin Tissue Adhesive Hemostasis, Surgical Humans Laparoscopy Laparoscopy Operative Time Ovarian Diseases Ovarian Diseases Postoperative Period

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:25.745717+00:00
License: CC0 · commercial use OK